C4 Therapeutics
CCCC
CCCC
83 hedge funds and large institutions have $64.5M invested in C4 Therapeutics in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
31% less capital invested
Capital invested by funds: $94.1M → $64.5M (-$29.6M)
70% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 23
Holders
83
Holding in Top 10
1
Calls
$24K
Puts
$30K
Top Buyers
| 1 | +$3.84M | |
| 2 | +$2.29M | |
| 3 | +$1.9M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.01M |
| 5 |
M&T Bank
Buffalo,
New York
|
+$260K |
Top Sellers
| 1 | -$1.8M | |
| 2 | -$1.77M | |
| 3 | -$1.19M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$858K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$513K |